SEC Form 4 · accession 0001179110-15-010823
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean-Yves Pavee
Officer — Senior Vice President
Period of report
Jul 1, 2015
Accepted (ET)
Jul 2, 2015 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par valueF1 | Jul 1, 2015 | A | 6,076 | $0.00 | A | 31,682 | D | |
| Common shares without par value | Jul 1, 2015 | F | 2,431 | $49.08 | D | 29,251 | D | |
| Common shares without par valueF2 | holding | — | — | — | 2,711 | I | Profit Sharing Trust | |
| Common shares without par valueF3 | holding | — | — | — | 2,967 | I | By daughter | |
| Common shares without par valueF3 | holding | — | — | — | 2,966 | I | By daughter | |
| Common shares without par valueF4 | holding | — | — | — | 2,966 | I | By son |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3.
- F2Balance in the Abbott Laboratories Stock Retirement Trust as of July 1, 2015.
- F3The reporting person disclaims beneficial ownership of all securities held by his daughter.
- F4The reporting person disclaims beneficial ownership of all securities held by his son.